iGeneTech
Beijing
About iGeneTech
iGeneTech is a high-tech enterprise located in the Zhongguancun Life Science Park in Beijing. Aiji Taikang focuses on the research and development of high-throughput sequencing targeted capture technology and the design and production of genetic testing products. It is a production service platform company driven by genetic testing technology. Relying on the core technologies of liquid crystal probe capture (TargetSeq®) and multiplex PCR amplification capture (MultipSeq®), Aiji Taikang has formed a gene capture reagent and kit, capture sequencing solution, and synthetic biology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2019)
- Website: igenetech.com
- Phone: +86 108-914-6623
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/igenetech-61654 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.